The Value of CINtec® PLUS Cytology Test in Cervical Cancer Screening

Advances in Women's Health

Contenido proporcionado por ReachMD. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente ReachMD o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

8M ago

MP3•Episodio en casa

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on January 08, 2025 16:37 (25d ago)

What now? This series will be checked again in the next hour. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

Host: Jennifer Caudle, DO
Guest: Tamera A. Paczos, MD, FACOG, FACP
The utility of p16 and Ki-67 immunostaining in biopsies has helped lead to the development of dual staining in cytology specimens. So what do clinicians need to know about the dual stain cytology test? Take a deep dive into this topic as Dr. Jennifer Caudle is joined by Dr. Tamera A. Paczos, Vice President, Associate Chief Medical Officer with BioReference Laboratories.

COBAS and CINTEC are trademarks of Roche.
All other product names and trademarks are the property of their respective owners. 02/23

121 episodios

#Science #Medicine #ReachMD #Health and Well-Being #Breast Cancer